China Pharma Holdings (CPHI) Current Leases (2019 - 2025)
Historic Current Leases for China Pharma Holdings (CPHI) over the last 7 years, with Q3 2025 value amounting to $70326.0.
- China Pharma Holdings' Current Leases rose 1674.11% to $70326.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $70326.0, marking a year-over-year increase of 1674.11%. This contributed to the annual value of $39323.0 for FY2024, which is 4940.88% down from last year.
- As of Q3 2025, China Pharma Holdings' Current Leases stood at $70326.0, which was up 1674.11% from $19776.0 recorded in Q1 2025.
- In the past 5 years, China Pharma Holdings' Current Leases registered a high of $86672.0 during Q1 2022, and its lowest value of $19776.0 during Q1 2025.
- In the last 5 years, China Pharma Holdings' Current Leases had a median value of $75425.0 in 2023 and averaged $63533.0.
- As far as peak fluctuations go, China Pharma Holdings' Current Leases crashed by 7621.26% in 2023, and later surged by 27970.61% in 2024.
- Over the past 5 years, China Pharma Holdings' Current Leases (Quarter) stood at $85282.0 in 2021, then tumbled by 52.57% to $40445.0 in 2022, then soared by 92.18% to $77727.0 in 2023, then crashed by 49.41% to $39323.0 in 2024, then skyrocketed by 78.84% to $70326.0 in 2025.
- Its Current Leases was $70326.0 in Q3 2025, compared to $19776.0 in Q1 2025 and $39323.0 in Q4 2024.